TrueBlue Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for TrueBlue in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" TrueBlue stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TBI, but not buy additional shares or sell existing shares.
View analyst ratings for TrueBlue or view top-rated stocks.

Wall Street analysts have given TrueBlue a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but TrueBlue wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

TrueBlue is scheduled to release its next quarterly earnings announcement on Monday, April 26th 2021.
View our earnings forecast for TrueBlue.

TrueBlue will be holding an earnings conference call on Monday, April 26th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

TrueBlue, Inc. (NYSE:TBI) announced its quarterly earnings data on Wednesday, February, 3rd. The business services provider reported $0.33 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.18 by $0.15. The business services provider had revenue of $518.63 million for the quarter, compared to analysts' expectations of $498.02 million. TrueBlue had a positive trailing twelve-month return on equity of 3.97% and a negative net margin of 7.36%. The business's revenue for the quarter was down 12.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.39 EPS.
View TrueBlue's earnings history.

TrueBlue's stock was trading at $13.35 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TBI stock has increased by 67.6% and is now trading at $22.38.
View which stocks have been most impacted by COVID-19.

5 analysts have issued 12-month price objectives for TrueBlue's stock. Their forecasts range from $16.00 to $24.00. On average, they expect TrueBlue's stock price to reach $18.75 in the next year. This suggests that the stock has a possible downside of 16.2%.
View analysts' price targets for TrueBlue or view top-rated stocks among Wall Street analysts.

34 employees have rated TrueBlue CEO Patrick Beharelle on Glassdoor.com. Patrick Beharelle has an approval rating of 56% among TrueBlue's employees. This puts Patrick Beharelle in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to TrueBlue include Tradeweb Markets (TW), Robert Half International (RHI), ManpowerGroup (MAN), ASGN (ASGN), Korn Ferry (KFY), Insperity (NSP), Kforce (KFRC), Kelly Services (KELYA), Heidrick & Struggles International (HSII), Barrett Business Services (BBSI), GP Strategies (GPX) and Hudson Global (HSON).
View all of TBI's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other TrueBlue investors own include International Business Machines (IBM), Intel (INTC), NVIDIA (NVDA), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), The Goldman Sachs Group (GS), AT&T (T), Zynga (ZNGA), AbbVie (ABBV) and Amgen (AMGN).

TrueBlue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

TrueBlue's stock is owned by a number of retail and institutional investors. Top institutional investors include New York State Teachers Retirement System (0.24%), Pacer Advisors Inc. (0.19%), Exchange Traded Concepts LLC (0.14%), State of Alaska Department of Revenue (0.07%), 6 Meridian (0.06%) and Crossmark Global Holdings Inc. (0.03%). Company insiders that own TrueBlue stock include A Patrick Beharelle, Carl Schweihs, Colleen B Brown, Derrek Lane Gafford, James E Defebaugh, Jeffrey B Sakaguchi and Taryn R Owen.
View institutional ownership trends for TrueBlue.

TBI stock was sold by a variety of institutional investors in the last quarter, including Exchange Traded Concepts LLC, New York State Teachers Retirement System, State of Alaska Department of Revenue, and 6 Meridian. Company insiders that have sold TrueBlue company stock in the last year include Carl Schweihs, Colleen B Brown, and Taryn R Owen.
View insider buying and selling activity for TrueBlue or view top insider-selling stocks.

TBI stock was acquired by a variety of institutional investors in the last quarter, including Pacer Advisors Inc., and Crossmark Global Holdings Inc..
View insider buying and selling activity for TrueBlue or or view top insider-buying stocks.

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TBI stock can currently be purchased for approximately $22.38.

TrueBlue has a market capitalization of $793.93 million and generates $2.37 billion in revenue each year. The business services provider earns $63.07 million in net income (profit) each year or $2.05 on an earnings per share basis.

TrueBlue employs 5,200 workers across the globe.

The official website for TrueBlue is www.trueblue.com.

TrueBlue is headquartered at 1015 A STREET, TACOMA WA, 98402.

TrueBlue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at 253-383-9101 or via email at [email protected]